Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cystamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystamine SCHEMBL28842776 | 1.00 | MAPT (1.00) | — | |
| Cystamine SCHEMBL28235943 | 1.00 | MAPT (1.00) | — | |
| Cystamine SCHEMBL345893 | 1.00 | MAPT (1.00) | — | |
| Cystamine SCHEMBL320311 | 1.00 | MAPT (1.00) | — | |
| Cystamine SCHEMBL28418529 | 0.96 | MAPT (0.92) | — | |
| Cystamine SCHEMBL7903150 | 0.96 | MAPT (0.92) | — | |
| Cystamine SCHEMBL28409923 | 0.96 | MAPT (0.92) | — | |
| Cystamine SCHEMBL43866 | 0.95 | — | — | |
| Cystamine SCHEMBL3648870 | 0.95 | TSHR (1.00) | — | |
| Cystamine SCHEMBL11040994 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 729 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117186424-B | Hydrogel delivery system based on dextran groups and zwitterionic groups and anti-tumor preparation | 山东大学 | 2026-05-19 | — | — | CN | claimed |
| US-12616948-B2 | Polyamide microcapsules | FIRMENICH SA (CH) | 2026-05-05 | — | — | US | claimed |
| EP-4717352-A1 | A WHOLE-BLOOD COMPATIBLE MATRIX FOR EXTRACORPOREAL BLOOD TREATMENT | Gambro Lundia AB (SE) | 2026-04-01 | — | — | EP | claimed |
| EP-4717351-A1 | A WHOLE-BLOOD COMPATIBLE DOUBLE-PEGYLATED MATRIX FOR EXTRACORPOREAL BLOOD TREATMENT | Gambro Lundia AB (SE) | 2026-04-01 | — | — | EP | claimed |
| US-12508565-B2 | Polyamide microcapsules | FIRMENICH SA (CH) | 2025-12-30 | — | — | US | claimed |
| EP-4633791-A1 | PROTEIN-BASED MICROCAPSULES | Firmenich SA (CH) | 2025-10-22 | — | — | EP | claimed |
| US-20250281371-A1 | PLANT PROTEIN-BASED MICROCAPSULES | FIRMENICH SA (CH) | 2025-09-11 | — | — | US | claimed |
| CN-120115098-A | Method for producing polyamide microcapsules | 弗门尼舍有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-119842130-A | High-toughness halogen-free flame-retardant crosslinked cable and preparation method thereof | 云南巨力电缆股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| WO-2025049143-A1 | IONIZABLE PILLARARENE ANTICOAGULANT | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2025-03-06 | — | — | WO | claimed |
| CN-104587473-B | A kind of preparation method to mesoporous apatite nano-medicament carrier of the liver cancer cells with reduction response and cell-targeting | 哈尔滨工业大学 | 2017-10-03 | — | — | CN | claimed |
| CN-106732474-A | A kind of magnetic Nano material and preparation method thereof and the application in enrichment analysis glycopeptide segment | 复旦大学 | 2017-05-31 | — | — | CN | claimed |
| CN-105688226-B | Intelligent GO (graphene oxide) drug carrier with supermolecule sensitive detaching capacity, preparation method and application | 西北大学 | 2017-05-10 | — | — | CN | claimed |
| CN-105906824-A | Preparation method of injectable in-situ self-assembled sodium hyaluronate hydrogel | 上海其胜生物制剂有限公司 | 2016-08-31 | — | — | CN | claimed |
| CN-105660409-A | Huai-pearl chrysanthemum tissue culture method | 邓珂 | 2016-06-15 | — | — | CN | claimed |
| CN-105646732-A | Preparation method of sodium hyaluronate derivative with oxidation-reduction response | 上海其胜生物制剂有限公司 | 2016-06-08 | — | — | CN | claimed |
| US-9173840-B2 | Multifunctional self-assembling polymeric nanosystems | NORTHEASTERN UNIVERSITY (US) | 2015-11-03 | — | — | US | claimed |
| US-6132955-A | Method for derivitizing electrodes and assay methods using such derivitized electrodes | IGEN INTERNATIONAL, INC. (US) | 2000-10-17 | — | — | US | claimed |
| WO-1996036870-A1 | METHOD FOR DERIVITIZING ELECTRODES AND ASSAY METHODS USING SUCH DERIVITIZED ELECTRODES | IGEN, INC. (US) | 1996-11-21 | — | — | WO | claimed |
| EP-0021991-B1 | CYSTAMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1982-05-05 | — | — | EP | claimed |